Switch to:

OncoMed Pharmaceuticals Inc (OMED) Ownership Data

Short Interest History (%)

This is the historical short interest of OncoMed Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest
May 13, 20167.54
April 29, 20166.07
April 15, 20167.02
March 31, 20168.03
March 15, 20168.07
February 29, 20168.56
February 12, 20169.49
January 29, 201611.6
January 15, 201611.39
December 31, 20159.83
December 15, 20159.48
November 30, 20159.39
November 13, 20158.93
October 30, 20159.24
October 15, 201510.84
September 30, 201511.11
September 15, 201511.71
August 31, 201511.77
August 14, 201510.81
July 31, 201510.16
July 15, 20159.32
June 30, 20158.91
June 15, 20159.27
May 29, 20159.12
May 15, 20158.79
April 30, 20158.29
April 15, 201513.49
March 31, 201513.25
March 13, 201513.88
February 27, 201514.51
February 13, 201516.02
January 30, 201517.89
January 15, 201520.54
December 31, 201420.23
December 15, 201421.92
November 28, 201422.41
November 14, 201422.77
October 31, 201423.32
October 15, 201421.85
September 30, 201420.73
September 15, 201418.28
August 29, 201416.71
August 15, 201415.9
July 31, 201416.37
July 15, 201416.32
June 30, 201413.94
June 13, 201414.56
May 30, 201414.66
May 15, 201415.44
April 30, 201415.84
April 15, 201423.76
March 31, 201421.6
March 14, 201422.04
February 28, 201421.67
February 14, 201421.42
January 31, 201419.01
January 15, 201419.51
December 31, 201318.37
December 13, 201315.2
November 29, 201313.81
November 15, 201312.02
October 31, 201311.17
October 15, 20139.36
September 30, 20138.25
September 13, 20136.56
August 30, 20136.43
August 15, 20135.62
July 31, 20132.89

Institutional Ownership History (%)

This the Institutional Ownership History of OncoMed Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
March 31, 201633.76
December 31, 201550.41
September 30, 201536.4
June 30, 201535.28
March 31, 201533.53
December 31, 201479.48
September 30, 201426.15
June 30, 201422.99
March 31, 201420.81
December 31, 201376.6
September 30, 201315.85

Insider ownership (%)

This is the historical insider ownership of OncoMed Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20161.07
March 31, 20160.97
February 29, 20160.98
January 31, 20160.98
December 31, 20150.97
November 30, 20151.02
October 31, 20151
September 30, 20151.04
August 31, 20150.96
July 31, 20150.96
June 30, 20151.01
May 31, 20151.01
April 30, 20151.03
March 31, 20151.04
February 28, 20151.05
January 31, 20151.06
December 31, 20140.66
November 30, 20141.01
October 31, 20141.03
September 30, 20141.04
August 31, 20141.05
July 31, 20140.95
June 30, 20140.97
May 31, 20140.98

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Jack W. LasersohnDirector77,0870.25%2016-03-17
Dr. Jonathan D. Root,M.D.N/A65,0910.21%2015-11-30
Dr. Timothy Hoey, PhDSVP, Cancer Biology47,1810.16%2016-01-06
Dr. Austin Gurney, PhDSee Remarks33,2570.11%2016-01-06
Paul J. HastingsChairman & CEO22,025less than 0.1%2016-01-06
Dr. Jakob Dupont, M.D.SVP & Chief Medical Officer20,642less than 0.1%2016-01-11
Dr. John A. Lewicki, PhDEVP & Chief Scientific Officer17,838less than 0.1%2016-01-06
Mr. Sunil PatelSee Remarks17,838less than 0.1%2016-01-06
Dr. Alicia J. Hager, PhDVP & General Counsel13,377less than 0.1%2016-01-06
Dr. Laurence Lasky, PhDN/A10,332less than 0.1%2015-11-30

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Morgenthaler Management Partners VII, LLC2,509,6722015-12-318.33N/A56,568
Presidio Management Group VIII, L.L.C.2,038,2722015-12-316.77N/A45,943
Vertical Group Lp1,910,0272016-03-176.31N/A18,203
Adams Street Partners LLC   Premium Plus1,839,7302015-12-316.117.1241,468
Bvf Inc   Premium Plus1,339,3362016-03-314.423.3513,541
Fidelity Management and Research Company   Premium Plus911,3032016-03-313.01N/A9,213
BlackRock Fund Advisors   Premium Plus823,3982016-03-312.72N/A8,325
Fidelity® Select Biotechnology Portfolio778,4332016-04-302.570.099,653
Vanguard Group Inc   Premium Plus600,9282016-03-311.98N/A6,075
Iguana Healthcare Management, LLC   Premium Plus467,0252016-03-311.541.734,722

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK